Aimmune Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aimmune Therapeutics, Inc.
CIK #0001631650
EDGAR Form CIK 2011 - 2025
10-K [0001631650]
10-Q [0001631650]
3 [0001631650]
4 [0001631650]
5 [0001631650]
8-K [0001631650]
D [0001631650]
SC 13D [0001631650]
SC 13G [0001631650]
Form 13D/13G Filer Form 13D/13G Subject Filed
Palo Alto Investors LP Aimmune Therapeutics Inc [2020-02-14]
Price T Rowe Associates Inc /MD/ Aimmune Therapeutics Inc [2019-02-14]
Nestle Health Science US Holdings Inc Aimmune Therapeutics Inc [2018-03-05]
Vanguard Group Inc Aimmune Therapeutics Inc [2018-02-08]
BlackRock Inc Aimmune Therapeutics Inc [2018-02-01]
Nestle Health Science US Holdings Inc Aimmune Therapeutics Inc [2016-11-28]
Sunshine Charitable Foundation Aimmune Therapeutics Inc [2016-02-10]
Aisling Capital III LP Aimmune Therapeutics Inc [2016-02-05]
Explore Holdings LLC Aimmune Therapeutics Inc [2016-01-29]
Longitude Capital Partners II LLC Aimmune Therapeutics Inc [2016-01-29]
View All
Form 3/4/5 Subject 2011 - 2025
Aimmune Therapeutics, Inc.
Societe des Produits Nestle S.A.
Oxtoby Andrew
Sheehy Douglas T.
Dallas Jayson Donald Alexander
McDade Mark
Behar Gregory
Haumann Brett K
Seltzer Stacey Denenberg
Bjerkholt Eric
View All
Terms | Privacy | Guide
tony@aum13f.com